pantoprazole has been researched along with Eye Cancer, Retinoblastoma in 1 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pascual-Pasto, G | 1 |
Olaciregui, NG | 1 |
Opezzo, JAW | 1 |
Castillo-Ecija, H | 1 |
Cuadrado-Vilanova, M | 1 |
Paco, S | 1 |
Rivero, EM | 1 |
Vila-Ubach, M | 1 |
Restrepo-Perdomo, CA | 1 |
Torrebadell, M | 1 |
Suñol, M | 1 |
Schaiquevich, P | 1 |
Mora, J | 1 |
Bramuglia, GF | 1 |
Chantada, GL | 1 |
Carcaboso, AM | 1 |
1 other study available for pantoprazole and Eye Cancer, Retinoblastoma
Article | Year |
---|---|
Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; ATP Binding Cassette Transporter, Subfamily B, Mem | 2017 |